The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endometriosis is defined as the colonization and growth of endometrial tissue at anatomic sites outside the uterine cavity. Up to 15% of reproductive-aged women in the USA suffer from painful symptoms of endometriosis, such as infertility, pelvic pain, menstrual cycle abnormalities and increased risk of certain cancers. However, many of the current clinical treatments for endometriosis are not sufficiently effective and yield unacceptable side effects. There is clearly an urgent need to identify new molecular mechanisms that critically underpin the initiation and progression of endometriosis in order to develop more specific and effective therapeutics which lack the side effects of current therapies. The aim of this review is to discuss how nuclear receptors (NRs) and their coregulators promote the progression of endometriosis. Understanding the pathogenic molecular mechanisms for the genesis and maintenance of endometriosis as modulated by NRs and coregulators can reveal new therapeutic targets for alternative endometriosis treatments. METHODS: This review was prepared using published gene expression microarray data sets obtained from patients with endometriosis and published literature on NRs and their coregulators that deal with endometriosis progression. Using the above observations, our current understanding of how NRs and NR coregulators are involved in the progression of endometriosis is summarized. RESULTS: Aberrant levels of NRs and NR coregulators in ectopic endometriosis lesions are associated with the progression of endometriosis. As an example, endometriotic cell-specific alterations in gene expression are correlated with a differential methylation status of the genome compared with the normal endometrium. These differential epigenetic regulations can generate favorable cell-specific NR and coregulator milieus for endometriosis progression. Genetic alterations, such as single nucleotide polymorphisms and insertion/deletion polymorphisms of NR and coregulator genes, are frequently detected in ectopic lesions compared with the normal endometrium. These genetic variations impart new molecular properties to NRs and coregulators to increase their capacity to stimulate progression of endometriosis. Finally, post-translational modifications of NR coregulators, such as proteolytic processing, generate endometriosis-specific isoforms. Compared with the unmodified coregulators, these coregulator isoforms have unique functions that enhance the pathogenesis of endometriosis. CONCLUSIONS: Epigenetic/genetic variations and posttranslational modifications of NRs and coregulators alter their original function so that they become potent 'drivers' of endometriosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802 · cited 2×
“The Breast Cancer 1, Early Onset (BRCA1) gene was identified as a tumor suppressor because its main function is to repair damaged DNA and ensure genomic stability (Chen and Parmigiani, 2007).”
BackgroundBulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · cited 2×
“Previous studies have revealed that certain types of NR family members, such as Liver X Receptor (LXR), peroxisome proliferatoractivated receptor (PPAR) and glucocorticoid receptor (GR), negatively modulate inflammatory signaling pathways by ligand-dependent binding of NRs to negative regulatory elements of inflammato…”
BackgroundSchug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
Lala, D. S. (1992) · Molecular Endocrinology · doi:10.1210/me.6.8.1249 · Cited by 678 · cited 1×
“SF-1 has been known to be a key modulator of steroidogenesis since the early 1990s (Lala et al., 1992; Morohashi et al., 1992; Giguere, 2008).”
BackgroundGene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606 · cited 2×
“Previous studies have revealed that certain types of NR family members, such as Liver X Receptor (LXR), peroxisome proliferatoractivated receptor (PPAR) and glucocorticoid receptor (GR), negatively modulate inflammatory signaling pathways by ligand-dependent binding of NRs to negative regulatory elements of inflammato…”
BackgroundProgesterone resistance in endometriosis: link to failure to metabolize estradiol.
Bulun, S. E., Cheng, Y.-H., Yin, P., Imir, G., Utsunomiya, H., Attar, E., Innes, J., & Julie Kim, J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.041 · Cited by 397
Genetic influences on endometriosis in an Australian twin sample
Treloar, S. A., O’Connor, D. T., O’Connor, V. M., & Martin, N. G. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00540-8 · Cited by 353 · cited 1×
“In addition to studies of relatives, twin studies of endometriosis have revealed an increased concordance of endometriosis in monozygotic twins compared with dizygotic twins (Treloar et al., 1999, 2002).”
ResultPromoter Methylation Regulates Estrogen Receptor 2 in Human Endometrium and Endometriosis1
Xue, Q., Lin, Z., Cheng, Y.-H., Huang, C.-C., Marsh, E., Yin, P., Milad, M. P., Confino, E., Reierstad, S., Innes, J., et al. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.107.061804 · Cited by 346 · cited 3×
“However, ERb (Xue et al., 2007a, b), SF-1 (Xue et al., 2007a, b) and aromatase (Izawa et al., 2008) genes are hypomethylated in endometriotic tissues.”
BackgroundRole of Estrogen Receptor-β in Endometriosis
Bulun, S., Monsavais, D., Pavone, M., Dyson, M., Xue, Q., Attar, E., Tokunaga, H., & Su, E. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1299596 · Cited by 321 · cited 2×
“Interestingly, elevated ERb enhances progesterone resistance in endometriotic tissues (Bulun et al., 2012).”
BackgroundPromoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis
Wu, Y., Strawn, E., Basir, Z., Halverson, G., & Guo, S.-W. (2006) · Epigenetics · doi:10.4161/epi.1.2.2766 · Cited by 321
Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis
Painter, J. N., Anderson, C. A., Nyholt, D. R., Macgregor, S., Lin, J., Lee, S. H., Lambert, A., Zhao, Z. Z., Roseman, F., Guo, Q., et al. (2011) · Nature Genetics · doi:10.1038/ng.731 · Cited by 308 · cited 1×
“2 is associated with a European endometriosis cohort (Painter et al., 2011).”
BackgroundProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Wu, Y., Halverson, G., Basir, Z., Strawn, E., Yan, P., & Guo, S.-W. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.034 · Cited by 283 · cited 2×
“, 2007a, b) and HOXA10 (Wu et al., 2005), show hypermethylation in their promoter and other regions in endometriosis compared with the normal endometrium.”
BackgroundMinireview: steroidogenic factor 1: its roles in differentiation, development, and disease
Schimmer, B. P., & White, P. C. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0519 · Cited by 268
Uno, S., Zembutsu, H., Hirasawa, A., Takahashi, A., Kubo, M., Akahane, T., Aoki, D., Kamatani, N., Hirata, K., & Nakamura, Y. (2010) · Nature Genetics · doi:10.1038/ng.612 · Cited by 259
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00393-3 · Cited by 256 · cited 2×
“…endometrium, endometriotic tissues have higher concentrations of estradiol-17b (E2) and locally elevated levels of steroidogenic factor 1 (SF-1) and aromatase, along with reduced activity of 17b-hydroxysteroid dehydrogenase-2 (Zeitoun and Bulun, 1999; Bulun, 2009; Bulun et al., 2009, 2010a, b).”
BackgroundMethodEstrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis
Bulun, S., Cheng, Y.-H., Pavone, M., Xue, Q., Attar, E., Trukhacheva, E., Tokunaga, H., Utsunomiya, H., Yin, P., Luo, X., et al. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242991 · Cited by 243 · cited 3×
“…endometriotic tissues from locally elevated levels of aromatase along with reduced activity of 17b-hydroxysteroid dehydrogenase-2 (Brosens et al.; Bulun et al., 2010a, b), current endometriosis treatments also involve suppressing E2 levels through the use of GnRH agonists (Descamps and Lansac,…”
BackgroundXue, Q., Lin, Z., Yin, P., Milad, M. P., Cheng, Y.-H., Confino, E., Reierstad, S., & Bulun, S. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0494 · Cited by 219 · cited 3×
“However, ERb (Xue et al., 2007a, b), SF-1 (Xue et al., 2007a, b) and aromatase (Izawa et al., 2008) genes are hypomethylated in endometriotic tissues.”
BackgroundThe search for genes contributing to endometriosis risk
Montgomery, G. W., Nyholt, D. R., Zhao, Z. Z., Treloar, S. A., Painter, J. N., Missmer, S. A., Kennedy, S. H., & Zondervan, K. T. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn016 · Cited by 211
Wu, Y., Strawn, E., Basir, Z., Halverson, G., & Guo, S.-W. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.05.077 · Cited by 193 · cited 4×
“Interestingly, expression levels of DNMT3A and DNMT3B are highly elevated in the ectopic endometrium compared with the normal endometrium or the eutopic endometrium of women with endometriosis (Wu et al., 2007a, b; van Kaam et al., 2011).”
BackgroundInfluentialInflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis
Bukulmez, O., Hardy, D. B., Carr, B. R., Word, R. A., & Mendelson, C. R. (2008) · Endocrinology · doi:10.1210/en.2007-0665 · Cited by 186 · cited 4×
“However, some endometriotic tissues have higher levels of PR-B expression compared with the normal endometrium (Misao et al., 1999; Bukulmez et al., 2008).”
BackgroundResultInfluentialAromatase inhibitors: the next generation of therapeutics for endometriosis?
Attar, E., & Bulun, S. E. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.064 · Cited by 184
Mechanisms of endometrial progesterone resistance
Al-Sabbagh, M., Lam, E. W.-F., & Brosens, J. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.035 · Cited by 183
Schug, T. T., Berry, D. C., Toshkov, I. A., Cheng, L., Nikitin, A. Y., & Noy, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709981105 · Cited by 172 · cited 2×
“In pathological cell types, however, RA paradoxically induces cell survival signaling pathways because RA binds to fatty acid-binding protein 5 (FABP5), which delivers RA to a different NR, PPAR b/d and induces the expression of prosurvival genes (Schug et al., 2008).”
BackgroundBrandenberger, A. W. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.7.651 · Cited by 165 · cited 1×
“In contrast to the modest changes in ERa expression described above, markedly elevated levels of ERb are detected in endometriotic tissues in mice with endometriosis and in human endometriotic tissues compared with normal endometrial tissues (Brandenberger et al., 1999; Han et al., 2012).”
BackgroundKennedy, S., Mardon, H., & Barlow, D. (1995) · Journal of Assisted Reproduction and Genetics · doi:10.1007/bf02214126 · Cited by 157
Han, S. J., Hawkins, S. M., Begum, K., Jung, S. Y., Kovanci, E., Qin, J., Lydon, J. P., DeMayo, F. J., & O'Malley, B. W. (2012) · Nature Medicine · doi:10.1038/nm.2826 · Cited by 149
Self-citationTrukhacheva, E., Lin, Z., Reierstad, S., Cheng, Y.-H., Milad, M., & Bulun, S. E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1466 · Cited by 143 · cited 6×
“This repressive role of ERb on ERa gene expression in endometriotic cells also has been confirmed by experiments knocking down and overexpressing ERb (Trukhacheva et al., 2009).”
BackgroundResultInfluentialExpression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis
Matsuzaki, S., Murakami, T., Uehara, S., Canis, M., Sasano, H., & Okamura, K. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01783-6 · Cited by 133 · cited 2×
“It is possible that ERa expression patterns differ depending upon the endometriotic sites (Matsuzaki et al., 2001; Colette et al., 2013).”
BackgroundResultExpression of oestrogen receptor-alpha and -beta in ovarian endometriomata
Fujimoto, J. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.8.742 · Cited by 123 · cited 1×
“…(ER)b levels in endometriotic tissues are much higher than in the normal endometrium, whereas ERa levels are not substantially different in endometriotic tissue versus normal endometrium; often they are reduced in endometriotic tissues compared with the normal endometrium (Fujimoto et al., 1999).”
BackgroundPROGINS receptor gene polymorphism is associated with endometriosis
Wieser, F., Schneeberger, C., Tong, D., Tempfer, C., Huber, J. C., & Wenzl, R. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02984-3 · Cited by 120 · cited 1×
“This polymorphism is closely associated with the progression of breast and ovarian cancer as well as the progression of endometriosis (Wieser et al., 2002; Lattuada et al., 2004; Pearce et al., 2005; Hu et al., 2012).”
BackgroundKulak, J., Fischer, C., Komm, B., & Taylor, H. S. (2011) · Endocrinology · doi:10.1210/en.2010-1010 · Cited by 112
Disturbed estrogen and progesterone action in ovarian endometriosis
Šmuc, T., Hevir, N., Ribič-Pucelj, M., Husen, B., Thole, H., & Rižner, T. L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.07.020 · Cited by 101 · cited 2×
“In addition, Smuc et al. (2009) have reported that there is no difference in the expression of the PR-B isoform at both mRNA and protein levels in endometriotic tissue versus normal endometrium.”
BackgroundResult17β-Hydroxysteroid Dehydrogenase-2 Deficiency and Progesterone Resistance in Endometriosis
Bulun, S., Cheng, Y.-H., Pavone, M., Yin, P., Imir, G., Utsunomiya, H., Thung, S., Xue, Q., Marsh, E., Tokunaga, H., et al. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242992 · Cited by 86 · cited 3×
“…endometriotic tissues from locally elevated levels of aromatase along with reduced activity of 17b-hydroxysteroid dehydrogenase-2 (Brosens et al.; Bulun et al., 2010a, b), current endometriosis treatments also involve suppressing E2 levels through the use of GnRH agonists (Descamps and Lansac,…”
BackgroundIzawa, M., Harada, T., Taniguchi, F., Ohama, Y., Takenaka, Y., & Terakawa, N. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.03.078 · Cited by 83 · cited 2×
“However, ERb (Xue et al., 2007a, b), SF-1 (Xue et al., 2007a, b) and aromatase (Izawa et al., 2008) genes are hypomethylated in endometriotic tissues.”
BackgroundSteroidogenic factor-1 and endometriosis
Bulun, S. E., Utsunomiya, H., Lin, Z., Yin, P., Cheng, Y.-H., Pavone, M. E., Tokunaga, H., Trukhacheva, E., Attar, E., Gurates, B., et al. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.012 · Cited by 80 · cited 1×
“…endometrium, endometriotic tissues have higher concentrations of estradiol-17b (E2) and locally elevated levels of steroidogenic factor 1 (SF-1) and aromatase, along with reduced activity of 17b-hydroxysteroid dehydrogenase-2 (Zeitoun and Bulun, 1999; Bulun, 2009; Bulun et al., 2009, 2010a, b).”
BackgroundOzawa, Y., Murakami, T., Tamura, M., Terada, Y., Yaegashi, N., & Okamura, K. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.057 · Cited by 76 · cited 1×
“Selective COX-2 inhibitors are often used as the first line of conventional treatment for this disorder (Ebert et al., 2005; Ozawa et al., 2006).”
BackgroundAltered retinoid uptake and action contributes to cell survival in endometriosis
Pavone, M. E., Reierstad, S., Sun, H., Milad, M., Bulun, S. E., & Cheng, Y.-H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0459 · Cited by 74 · cited 5×
“In the case of endometriosis, alternations in the molecular properties of NR coregulators, such as RA-binding protein 2 (Pavone et al., 2010), Breast Cancer 1 (Goumenou et al., 2003), tumor protein 53 (TP53) (Paskulin et al., 2012), hydrogenperoxide inducible clone 5 (Hic-5) (Aghajanova et al.,…”
BackgroundInfluentialInsights into assessing the genetics of endometriosis
Rahmioglu, N., Missmer, S. A., Montgomery, G. W., & Zondervan, K. T. (2012) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-012-0016-5 · Cited by 71 · cited 1×
“To this end, various factors have been identified across the genome and investigated to determine how genetics may play a role in endometriosis progression (Montgomery et al., 2008; Rahmioglu et al., 2012).”
Backgroundvan Kaam, K. J. A. F., Schouten, J. P., Nap, A. W., Dunselman, G. A. J., & Groothuis, P. G. (2008) · Human Reproduction · doi:10.1093/humrep/den153 · Cited by 70
Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS?
Lattuada, D., Somigliana, E., Viganò, P., Candiani, M., Pardi, G., & Di Blasio, A. M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02076.x · Cited by 64 · cited 1×
“This polymorphism is closely associated with the progression of breast and ovarian cancer as well as the progression of endometriosis (Wieser et al., 2002; Lattuada et al., 2004; Pearce et al., 2005; Hu et al., 2012).”
Backgroundvan Kaam, K. J. A. F., Delvoux, B., Romano, A., D’Hooghe, T., Dunselman, G. A. J., & Groothuis, P. G. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.031 · Cited by 64
Yao, Z., Shen, X., Capodanno, I., Donnelly, M., Fenyk-Melody, J., Hausamann, J., Nunes, C., Strauss, J., & Vakerich, K. (2005) · Journal of Investigative Surgery · doi:10.1080/08941930591004412 · Cited by 60
Shen, L., Yang, S., Huang, W., Xu, W., Wang, Q., Song, Y., & Liu, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3010 · Cited by 57 · cited 2×
“For example, both miR23a and miR23b are down-regulated in endometriotic tissues compared with the normal endometrium, and their expression levels are inversely correlated with SF-1 mRNA levels (Shen et al., 2013) (Fig.”
BackgroundComparison of the effects of raloxifene and anastrozole on experimental endometriosis
Altintas, D., Kokcu, A., Kandemir, B., Tosun, M., & Cetinkaya, M. B. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.004 · Cited by 57
Tian, Y., Kong, B., Zhu, W., Su, S., & Kan, Y. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700513 · Cited by 25 · cited 1×
“Consistent with RNA levels of SF-1, protein levels of SF-1 were also significantly elevated in the ectopic endometrium compared with normal endometria, and the elevation of SF-1 levels was significantly correlated with the severity of endometriosis (Tian et al., 2009).”
BackgroundDing, X., Wang, L., Ren, Y., & Zheng, W. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.04.054 · Cited by 24 · cited 1×
“Generally, endometriotic lesions have apoptotic resistance and a modified protein pattern in their mitochondrial membranes because most apoptotic proteins are anchored to the mitochondrial membrane (Agic et al., 2009; Ding et al., 2010).”
Background
Cited by
Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?
Marquardt, R. M., Kim, T. H., Shin, J.-H., & Jeong, J.-W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153822 · Cited by 491
Han, S. J., Jung, S. Y., Wu, S.-P., Hawkins, S. M., Park, M. J., Kyo, S., Qin, J., Lydon, J. P., Tsai, S. Y., Tsai, M.-J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.10.034 · Cited by 380
Self-citationHormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Estrogen Receptors and Endometriosis
Chantalat, E., Valera, M.-C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., Vergriete, K., Buscail, E., Lluel, P., Fontaine, C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082815 · Cited by 297
Estrogen-Receptor Expression and Function in Female Reproductive Disease
Tang, Z.-R., Zhang, R., Lian, Z.-X., Deng, S.-L., & Yu, K. (2019) · Cells · doi:10.3390/cells8101123 · Cited by 274
Metadata
- Authors
- Han, S. J., & O'Malley, B. W.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-14
- Volume
- 20
- Issue
- 4
- Pages
- 467-484
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2161081282
- Cited by
- 99
- References
- 49
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.